Guangdong VTR Bio-Tech Co Ltd

Yiduoli released its 2026 interim report. Total operating revenue was 397 million yuan, down 4.38% year on year. Net profit attributable to the parent company was negative 4.87 million yuan, swinging from profit to loss, a decrease of 18.87 million yuan compared with the same period last year, a decline of 134.79%. Net cash inflow from operating activities was 18.01 million yuan. The asset-liability ratio was 8.75%, gross margin was 46.09%, return on equity was negative 0.19%, and diluted earnings per share was negative 0.01 yuan. The company had 18,000 shareholders, and the top ten shareholders held 42.02% of total share capital.